Zhenfa Zhang

19PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTumour immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 29, 2026
Heterogeneity of Cancer-Associated Fibroblasts and Precision Targeting Strategies for Cancer Therapy.

|Sep 24, 2025
Integrative Single-Cell and Machine Learning Analysis Reveals Immune Microenvironment Remodelling in Lymph Node Metastasis of Lung Adenocarcinoma.

Shuai Jiang, Jinhan Zhao, Jiaqi Feng

|Jul 31, 2025
Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma.

Pengpeng Zhang, Mengzhe Zhang, Jianlan Liu

|Mar 20, 2025
Identifying Lipid Metabolism-Related Therapeutic Targets and Diagnostic Markers for Lung Adenocarcinoma by Mendelian Randomization and Machine Learning Analysis.

Su Wei, Zhou Guangyao, Tian Xiangdong

|Feb 26, 2025
Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma.

Pengpeng Zhang, Dingli Wang, Guangyao Zhou

|Oct 25, 2024
Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma.

Lianmin Zhang, Yanan Cui, Guangyao Zhou

Pageof 4

Frequent Collaborators

4 joint publications

Changli Wang

3 joint publications

Zhang Lianmin

3 joint publications

Bin Jia

3 joint publications

Ting Gong